Immunotherapy with Keytruda (Pembolizumab) in Kyiv: Best Clinics and Costs 2026

Immunotherapy with Keytruda (Pembolizumab) in Kyiv typically costs from $3,400 to $6,100. The total price depends on the required number of treatment cycles, medication dosage, and the specific cancer type. In the US, similar treatments cost $21,500 on average. Patients save around 71% in Kyiv. Most clinics include medication, infusion sessions, bloodwork, and follow-up monitoring by an oncologist.

• Cycle quantity: Total cost scales directly with the number of sessions your oncologist prescribes.
• Combination protocols: Costs increase when clinics combine Keytruda with chemotherapy or other targeted agents.
• Clinic infrastructure: Large medical networks often maintain specialized oncology departments with on-site diagnostic labs.
• Monitoring frequency: Intensive follow-up care and frequent imaging can add 10-15% to the baseline.

Bookimed Expert Insight: Kyiv serves as Ukraine’s primary hub for high-volume oncology care with massive patient capacities. Large networks like Dobrobut Medical Network treat over 330,000 patients annually and follow strict ISO international standards. This scale allows these institutions to maintain lower operational costs than smaller clinics. Patients can access western-standard protocols at a fraction of the cost found in Germany or Israel.